top of page
Open Site Navigation

In-Person Only

End users who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for:

CXO's, VP's, Directors and Managers Responsible For

  • Technical Operations

  • Formulation And Stability 

  • Process Development

  • Intensified & Continuous Bioprocessing

  • Cell Therapy CMC Manufacturing

  • Gene Therapy Manufacturing

  • Gene Therapy | Cell Therapy

  • Biomedical Engineering

  • Cell Line Development

  • Regulatory Affairs

  • Cell Engineering

  • Supply Chain | Cold Chain

  • Stem Cell Manufacturing

  • Novel Vector Systems

  • Regenerative Medicine

Key Topics

  • Cell And Gene Therapies Commercialisation And Supply

  • Bringing New Therapeutic Modalities To Patients On A Global Scale

  • Commercialising Transformative Innovation: Lessons Learned

  • Trying To Be Different By Staying Inside The Box; A New CDMO Model Supporting Renewed Domestic Biomanufacturing In The US.

  • Streamline Scale-Up And Technology Transfer To CMOs

  • Execute Quality Systems Internally And Externally With Partners

  • Rethinking CDMO - Partnership, Selection, Negotiation, Tech Transfer, Life Cycle Management

  • Best Practices Of CMC Analytics For Cell And Gene Therapies

  • Examing Analytical Technologies And CMC Comparability Of Biotechnology Products

  • Discuss Data Integrity Challenges With Contract Manufacturers/CDMOs

  • Identifying Bioprocessing Innovations For Next-Generation Antibody-Based Modalities

  • Rethinking Global Supply Chain For Inventory Build And Planning

Co-Located Topics

  • Bio Innovation Topics 2023

  • Evolving And Digitising Toward Next-Generation Bioprocessing 

  • Digital Innovation And The Rise Of Immersive Technologies At Takeda

  • Creating An Effective Adoption Of Single-Use Systems And Continuous Bioprocessing

  • Continuous Integrated Bioprocessing For ATMPs

  • Smart Chromatography™ - A Method For Scalable Primary Purification, Removing The Clarification Bottlenecks

  • Build Flexible, Automated Multi-Product Manufacturing Facilities

  • Smart Process Design - AI-Enhanced Models For Cutting-Edge Process Development

  • Enhance Quality Metrics Readiness And Regulatory Expectations

  • The Future Of IMP Supplies: A Success Story

  • Application Of Various Models For Enhanced Process And Plant Utilisation."Digital Process Twins - Case Studies

  • Expanded Bed Adsorption Chromatography At Commercial Scale For Injectable Therapeutics

  • Innovation In Recovery And Purification

  • Implementation of a Digital and Online CPV Plan

Speakers 30%
End Users 60%
Buying power 90%
Vendors 10%

6th Annual CGTI Leaders Summit 2023
Advancing cell and gene therapies through strategic collaboration and technology innovation

Co-Located - 15th Annual BILS Leaders Summit
15th - 16th February 2023
Hotel Palace Berlin 5* - Germany

Learn more

Event details

Learn more

Register now

Learn more

Programme

"The Global Cell and Gene Therapy Market is estimated to be up to $67 Billion by 2030."

The 6th Annual Cell and Gene Therapy Innovation Summit is an exclusive in-person-only gathering for up to 200 decision-makers, intellectual vanguards and captains of industry.

With more regenerative medicine products approaching clinical testing and commercialisation, seize this opportunity to hear detailed insights and industry best practices from renowned presenters.

Achieve a deeper understanding of the many manufacturing and industrialisation burdens unique to carrying durable and curative therapies to needy patients.

The 6th Annual Cell And Gene Therapy Innovation Summit 2023

15th - 16th February 2023 - Hotel Palace Berlin 5* - Germany

Over Two Days

The Agenda

G

B

X